These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36045608)

  • 41. Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.
    Kumar D; Talluri TR; Anand T; Kues WA
    World J Stem Cells; 2015 Mar; 7(2):315-28. PubMed ID: 25815117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells.
    Haruta M; Tomita Y; Yuno A; Matsumura K; Ikeda T; Takamatsu K; Haga E; Koba C; Nishimura Y; Senju S
    Gene Ther; 2013 May; 20(5):504-13. PubMed ID: 22875043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel live cell fluorescent probe for human-induced pluripotent stem cells highlights early reprogramming population.
    Sriram S; Kang NY; Subramanian S; Nandi T; Sudhagar S; Xing Q; Tong GJ; Chen AK; Srijaya TC; Tan P; Loh YH; Chang YT; Sugii S
    Stem Cell Res Ther; 2021 Feb; 12(1):113. PubMed ID: 33546754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapy.
    Matsui T; Akamatsu W; Nakamura M; Okano H
    Exp Neurol; 2014 Oct; 260():12-8. PubMed ID: 23036600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic cloning and somatic cell reprogramming: every road leads to Rome].
    Yang J; Liu GQ; Hong TP
    Sheng Li Ke Xue Jin Zhan; 2009 Apr; 40(2):101-5. PubMed ID: 19558136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale.
    Lagarkova MA; Shutova MV; Bogomazova AN; Vassina EM; Glazov EA; Zhang P; Rizvanov AA; Chestkov IV; Kiselev SL
    Cell Cycle; 2010 Mar; 9(5):937-46. PubMed ID: 20160486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. iPS cell serves as a source of dendritic cells for in vitro dengue virus infection model.
    Manh DH; Mizukami S; Dumre SP; Raekiansyah M; Senju S; Nishimura Y; Karbwang J; Huy NT; Morita K; Hirayama K
    J Gen Virol; 2018 Sep; 99(9):1239-1247. PubMed ID: 30058991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influences of lamin A levels on induction of pluripotent stem cells.
    Zuo B; Yang J; Wang F; Wang L; Yin Y; Dan J; Liu N; Liu L
    Biol Open; 2012 Nov; 1(11):1118-27. PubMed ID: 23213392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming.
    Lee MR; Prasain N; Chae HD; Kim YJ; Mantel C; Yoder MC; Broxmeyer HE
    Stem Cells; 2013 Apr; 31(4):666-81. PubMed ID: 23255147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemical compound-based direct reprogramming for future clinical applications.
    Takeda Y; Harada Y; Yoshikawa T; Dai P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29739872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
    Playne R; Connor B
    Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules.
    Kang PJ; Moon JH; Yoon BS; Hyeon S; Jun EK; Park G; Yun W; Park J; Park M; Kim A; Whang KY; Koh GY; Oh S; You S
    Biomaterials; 2014 Aug; 35(26):7336-45. PubMed ID: 24881998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors.
    Si-Tayeb K; Noto FK; Sepac A; Sedlic F; Bosnjak ZJ; Lough JW; Duncan SA
    BMC Dev Biol; 2010 Aug; 10():81. PubMed ID: 20682060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave.
    Sharp B; Rallabandi R; Devaux P
    Mol Diagn Ther; 2022 Jul; 26(4):353-367. PubMed ID: 35763161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plant hormones increase efficiency of reprogramming mouse somatic cells to induced pluripotent stem cells and reduce tumorigenicity.
    Alvarez Palomo AB; McLenachan S; Requena Osete J; Menchón C; Barrot C; Chen F; Munné-Bosch S; Edel MJ
    Stem Cells Dev; 2014 Mar; 23(6):586-93. PubMed ID: 24251409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reprogrammed pluripotent stem cells from somatic cells.
    Kim JS; Choi HW; Choi S; Do JT
    Int J Stem Cells; 2011 Jun; 4(1):1-8. PubMed ID: 24298328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.